Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F.* , & Habraken, Y.*. (02 February 2023). The transcription factor c-Jun mediates specific reprogramming of pre-mRNA splicing during platinum-based therapy via RBM39 [Poster presentation]. séminaire des chercheurs Télévie 2023. * These authors have contributed equally to this work. |
Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Peulen, O., Rademaker, G., Deward, A., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F.* , & Habraken, Y.*. (09 December 2022). The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress. Nucleic Acids Research, 50 (22), 12768 - 12789. doi:10.1093/nar/gkac1130 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F.* , & Habraken, Y.*. (09 September 2022). The transcription factor c-Jun inhibits RBM39 to reprogram mRNA splicing during genotoxic stress [Poster presentation]. Interuniversity PhD student day. * These authors have contributed equally to this work. |
Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Dequiedt, F.* , & Habraken, Y.*. (08 April 2022). c-Jun directly controls spliceosome specificity through RBM39 binding in response to genotoxic chemotherapy [Poster presentation]. séminaire des chercheurs Télévie 2022. * These authors have contributed equally to this work. |
Lemaitre, F.* , Chakrama, F.* , Dequiedt, F.* , & Habraken, Y.*. (17 March 2022). c-Jun directly controls spliceosome specificity through RBM39 binding in response to genotoxic chemotherapy [Poster presentation]. Multiple facets of RNA in development and disease. * These authors have contributed equally to this work. |
Lemaitre, F., Chakrama, F., O'Grady, T., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F., & Habraken, Y. (March 2022). The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress [Poster presentation]. THE MULTIPLE FACETS OF RNA IN DEVELOPMENT AND DISEASE, Nice, France. |
Chakrama, F., Gabriel, M., Deward, A., Lassence, C., Colige, A., Lambert, C., & Habraken, Y. (September 2018). Alternative splicing induced by Cisplatin: effect on the shape of mitochondria [Poster presentation]. Joint meeting GIGA-Cancer Day 2018 / EDT-Cancerology. |
Chakrama, F., Lambert, C., Gabriel, M., Deward, A., Lassence, C., Colige, A., & Habraken, Y. (October 2017). Alternative splicing induced by cisplatin : Effect on mitochondria shape [Poster presentation]. Forty Years of mRNA Splicing: From Discovery to Therapeutics meeting, New-York, United States. |
Gabriel, M., Garbacki, N., Chakrama, F., Habraken, Y., Colige, A., & Lambert, C. (May 2017). Chemotherapy regulates the expression of alternative transcripts: relationship to the new hallmarks of cancer and therapeutic efficacy [Poster presentation]. International symposium on the Hallmarks of Cancer: Focus on RNA, Prague, Czechia. |
Tranchevent, L.-C., Aubé, F., Dulaurier, L., Benoit-Pilven, C., Rey, A., Poret, Chautard, E., Mortada, H., Desmet, F.-O., Chakrama, F., Moreno-Garcia, M. A., Goillot, E., Janczarski, S., Mortreux, F., Bourgeois, C., & Auboeuf, D. (2017). Identification of protein features encoded by alternative exons using Exon Ontology. Genome Research. doi:10.1101/gr.212696.116 Peer Reviewed verified by ORBi |
Dardenne, E., Polay Espinoza, M., Fattet, L., Germann, S., Lambert, M.-P., Neil, H., Zonta, E., Mortada, H., Gratadou, L., Deygas, M., Chakrama, F., Samaan, S., Desmet, F.-O., Tranchevent, L.-C., Dutertre, M., Rimokh, Bourgeois, & Auboeuf, D. (2014). RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. Cell Reports. doi:10.1016/j.celrep.2014.05.010 Peer Reviewed verified by ORBi |
Boyer-Guittaut, M., Poillet, L., Liang, Q., Bole-Richard, E., Ouyang, X., Benavides, G. A., Chakrama, F., Fraichard, A., Darley-Usmar, Despouy, G., Jouvenot, M., Delage-Mourroux, R., & Zhang, J. (2014). The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells. Autophagy. doi:10.4161/auto.28390 Peer Reviewed verified by ORBi |
Dutertre, M., Chakrama, F., Combe, E., Desmet, F.-O., Mortada, H., Polay Espinoza, M., Gratadou, L., & Auboeuf, D. (2014). A recently evolved class of alternative 3'-terminal exons involved in cell cycle regulation by topoisomerase inhibitors. Nature Communications. doi:10.1038/ncomms4395 Peer Reviewed verified by ORBi |
Seguin-Py, S., Lucchi, G., Croisier, S., Chakrama, F., Despouy, G., Legrand, J.-N., Ducoroy, P., Boireau, W., Boyer-Guittaut, M., Jouvenot, M., Fraichard, A., & Delage-Mourroux, R. (2012). Identification of HSP90 as a new GABARAPL1 (GEC1)-interacting protein. Biochimie. doi:10.1016/j.biochi.2011.11.006 Peer Reviewed verified by ORBi |
Legrand, J.-N., Chakrama, F., Seguin-Py, S., Fraichard, A., Delage-Mourroux, R., Jouvenot, M., & Boyer-Guittaut, M. (2011). GABARAPL1:original or copycat? Autophagy. Peer Reviewed verified by ORBi |
Legrand, J.-N., Chakrama, F., Seguin-Py, S., Fraichard, A., Delage-Mourroux, R., Jouvenot, M., Risold, P.-Y., & Boyer-Guittaut, M. (2011). GABARAPL1 antibodies: target one protein, get one free! Autophagy. Peer Reviewed verified by ORBi |
Chakrama, F., Seguin-Py, S., Legrand, J.-N., Fraichard, A., Delage-Mourroux, R., Despouy, G., Perez, V., Jouvenot, M., & Boyer-Guittaut, M. (2010). GABARAPL1 (GEC1) associates with autophagic vesicles. Autophagy. doi:10.4161/auto.6.4.11819 Peer Reviewed verified by ORBi |